Furthermore, a recent study demonstrated that NT-proBNP was an important predictor of poor prognosis and improved cardiovascular risk prediction beyond the SYNTAX II score in patients with a three-vessel disease (30). This evidence concerns the gene NPPB and glycogen storage disease VI.